Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effectiveness of OnabotulinumtoxinA vs Oral Tamsulosin in Men With Benign Prostatic Hyperplasia & Lower Urinary Track Symptoms
NCT01589263Phase 2Completed
- Sponsor
- VA Office of Research & Development
- Start
- Jun 2012
- Primary completion
- Sep 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of onabotulinumtoxinA in benign prostatic hyperplasia (BPH), lower urinary tract symptoms (LUTS), sponsored by VA Office of Research & Development. Started Jun 2012; status: completed.
02
Drugs
onabotulinumtoxinA
03
Conditions
benign prostatic hyperplasia (BPH)lower urinary tract symptoms (LUTS)
Beyond the preview
Go deeper on NCT01589263.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01589263.